All Blogs / Industries / Medical / Pharmaceutical / Posts With Audio


Tom Stossel Attempts to Debunk the Conflict-of-Interest "Myth"

Yesterday, I interviewed Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, about his new book, PharmaPhobia, and his call to action against the "Conflict of Interest Movement," which he claims undermines American medical innovation. Show More Summary

Delete This and Delete That, Says Novartis to FDA Regarding Recent Social Media Guidance

The comments are in! As usual, the pharma industry waited until the last second to submit comments to FDA Docket 2013-N-1430 regarding "Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive...Show More Summary

The Hawaiian Shirt is Ready for the Next Pharmaguy Social Media Pioneer Award Recipient!

In just a few weeks, I will be announcing the recipient(s) of the 4th Annual Pharmaguy Social Pioneer Award at the Digital Pharma East conference in Philadelphia. s part of the ceremony, I will pass on the famous -- or infamous, depending...Show More Summary

Janssen Engages HIV Community on Tumblr: Build It and They Will Come?

A few months ago, I engaged Peter Houston (@Flipping_Pages) in a discussion about whether or not pharma "should" do Tumblr, a social media site that allows users to post text, photos, quotes, links, music, and videos from browsers, phones, via email or wherever (see "Should Pharma Do Tumblr?"). Show More Summary

Goldacre speaks

Science Weekly Extra: An extended interview with Ben Goldacre on Bad Pharma http://audio.theguardian.tv/audio/kip/science/series/science/1350653685662/7287/gnl.sci.120122.jp.science_weekly_goldacrefull.mp3 In Science Extra this weekShow More Summary

Perspectives on the Drug Shortage Issue

The issue of drug shortages has surfaced periodically in the news and in policy circles for months, prompting both FDA and the Administration to various actions. For some, it may be an abstract notion – the idea that some drugs … Continue reading ?

Podcast on Avastin

As if hearing my voice on the page isn't enough, here's a podcast I did last week with Paul Howard of the Manhattan Institute on the FDA's Avastin decision. You might think that they'd be all worked up about this (a la the Wall Street Journal's editorial page), but you might be surprised...

Let the Sunshine Part 3 – Taking it on the Road: Transparency Outside the U.S.

The past two days have been focused on The Physician Payment Sunshine provisions of the Patient Protection Affordable Care Act in the U.S. which will require the reporting of financial relationships between medical product manufacturers and medical providers by 2013. … Continue reading ?

Podcast Interview on Drug Discovery

Here's an interview that I did recently with Paul Howard of the Manhattan Institute on the results of that immunotherapy leukemia trial (and on some broader topics around the current state of drug discovery). Anyone who would like to...Show More Summary

D-Day for Pharma and Facebook

It is another one of those questions – how did we get here?  For months FDA’s DDMAC did not seem to understand the impact of social media, then asked for help understanding how to regulate it, then failed to produce … Continue readi...

The need for new ways to define disease - Health Report - 23 May 2011

23 May 2011 The need for new ways to define disease listen now | download audio In a series of articles in the British Medical Journal Australian medical journalist Ray Moynihan argues that there are problems in the way diseases are defined. Show More Summary

Copyright © 2015 Regator, LLC